Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
38,000
Frequently Asked Questions
What is Market Cap of Mylan N.V.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Mylan N.V. market cap is $13.74B.
What is the 52-week high for Mylan N.V.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Mylan N.V. 52 week high is $13.62 as of September 20, 2025.
What is the 52-week low for Mylan N.V.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Mylan N.V. 52 week low is $8.74 as of September 20, 2025.
What is Mylan N.V. stock price today?
Mylan N.V. stock price today is $11.79.
What was Mylan N.V. stock price yesterday?
Mylan N.V. stock price yesterday was $11.57.
What is the PE ratio of Mylan N.V.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Mylan N.V.’s P/E ratio is 272.88.
What is the Price-to-Book ratio of Mylan N.V.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Mylan N.V. P/B ratio is 0.6788.
What is Mylan N.V.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Mylan N.V.'s EBITDA is 6.29.
What is the 50-day moving average of Mylan N.V.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Mylan N.V. 50-day moving average is $12.04.
